SE420565B - Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel - Google Patents

Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Info

Publication number
SE420565B
SE420565B SE7407462A SE7407462A SE420565B SE 420565 B SE420565 B SE 420565B SE 7407462 A SE7407462 A SE 7407462A SE 7407462 A SE7407462 A SE 7407462A SE 420565 B SE420565 B SE 420565B
Authority
SE
Sweden
Prior art keywords
intravascular administration
aid
suspension
solution
connection
Prior art date
Application number
SE7407462A
Other languages
English (en)
Other versions
SE7407462L (sv
Inventor
U S E Rothman
B J Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE7407462A priority Critical patent/SE420565B/sv
Priority to AU81647/75A priority patent/AU8164775A/en
Priority to DE19752524279 priority patent/DE2524279A1/de
Priority to US05/583,217 priority patent/US4124705A/en
Priority to CA228,793A priority patent/CA1037950A/en
Priority to GB24288/75A priority patent/GB1518121A/en
Priority to FR7517633A priority patent/FR2273555A1/fr
Priority to NL7506757A priority patent/NL7506757A/xx
Priority to JP50067730A priority patent/JPS6125689B2/ja
Publication of SE7407462L publication Critical patent/SE7407462L/sv
Publication of SE420565B publication Critical patent/SE420565B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7407462A 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel SE420565B (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
AU81647/75A AU8164775A (en) 1974-06-06 1975-05-29 An agent for intravascular administration
DE19752524279 DE2524279A1 (de) 1974-06-06 1975-05-31 Mittel zur intravaskulaeren verabreichung und verfahren zu seiner herstellung
US05/583,217 US4124705A (en) 1974-06-06 1975-06-02 Agent for intravascular administration
CA228,793A CA1037950A (en) 1974-06-06 1975-06-05 Agent for intravascular administration
GB24288/75A GB1518121A (en) 1974-06-06 1975-06-05 Agent for intravascular administration
FR7517633A FR2273555A1 (fr) 1974-06-06 1975-06-05 Agent d'administration intravasculaire
NL7506757A NL7506757A (nl) 1974-06-06 1975-06-06 Middel voor intravasculaire toediening.
JP50067730A JPS6125689B2 (sv) 1974-06-06 1975-06-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Publications (2)

Publication Number Publication Date
SE7407462L SE7407462L (sv) 1975-12-08
SE420565B true SE420565B (sv) 1981-10-19

Family

ID=20321349

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Country Status (9)

Country Link
US (1) US4124705A (sv)
JP (1) JPS6125689B2 (sv)
AU (1) AU8164775A (sv)
CA (1) CA1037950A (sv)
DE (1) DE2524279A1 (sv)
FR (1) FR2273555A1 (sv)
GB (1) GB1518121A (sv)
NL (1) NL7506757A (sv)
SE (1) SE420565B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283960A (en) * 1976-01-01 1977-07-13 Pharmacia Ab Medicine for administrating in blood
DE2908437A1 (de) * 1979-03-05 1980-09-18 Fresenius Chem Pharm Ind Vernetzte hydroxyaethylstaerke
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
US4431626A (en) * 1981-05-27 1984-02-14 The Regents Of The University Of California Tc-99m Labeled carrier for imaging
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
JPS62236839A (ja) * 1986-04-08 1987-10-16 Yoshiaki Motozato 架橋されたグルコマンナン球状粒子及びその製法
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
US5948387A (en) * 1990-06-01 1999-09-07 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
US5420176A (en) * 1990-06-01 1995-05-30 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
ATE130517T1 (de) * 1990-08-08 1995-12-15 Takeda Chemical Industries Ltd Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff.
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
US5233995A (en) * 1991-11-21 1993-08-10 Sterling Winthrop Inc. Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods
KR100304997B1 (ko) * 1992-07-24 2002-04-24 드니랑글로아 효소에의해제어되는약물방출을위한가교결합된폴리하이드록실물질을포함하는정제
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
ES2248817T3 (es) * 1995-06-06 2006-03-16 C.R. Bard, Inc. Procedimiento de preparacion de particulas reticuladas de polimeros hidrosolubles, las particulas obtenidas y su utilizacion.
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6261320B1 (en) 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
US5782742A (en) 1997-01-31 1998-07-21 Cardiovascular Dynamics, Inc. Radiation delivery balloon
US6491619B1 (en) 1997-01-31 2002-12-10 Endologix, Inc Radiation delivery catheters and dosimetry methods
US6458069B1 (en) 1998-02-19 2002-10-01 Endology, Inc. Multi layer radiation delivery balloon
US5993374A (en) * 1997-06-17 1999-11-30 Radiance Medical Systems, Inc. Microcapsules for site-specific delivery
US6048299A (en) * 1997-11-07 2000-04-11 Radiance Medical Systems, Inc. Radiation delivery catheter
US6149574A (en) * 1997-12-19 2000-11-21 Radiance Medical Systems, Inc. Dual catheter radiation delivery system
AU2687299A (en) 1998-02-19 1999-09-06 Radiance Medical Systems, Inc. Thin film radiation source
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
EP1255547B1 (en) 2000-02-08 2008-08-20 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
JP4885866B2 (ja) 2004-10-25 2012-02-29 セロノヴァ バイオサイエンスィズ ジャーマニー ゲーエムベーハー 治療適用および／または診断適用のための充填可能なポリホスファゼン含有粒子、ならびにその調製方法および使用方法
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
BRPI0712088B8 (pt) 2006-05-31 2021-06-22 Baxter Healthcare Sa uso de uma biomatriz de lâmina de colágeno de múltiplas camadas microscópicas não porosa e hermética a fluido
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
CA2703103C (en) 2007-10-30 2017-05-09 Baxter Healthcare S.A. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
CN102802683B (zh) 2009-06-16 2015-11-25 巴克斯特国际公司 止血海绵
EP2467060A2 (en) 2009-08-18 2012-06-27 Ben Gurion University Of The Negev Research And Development Authority System and method for analyzing imaging data
US8771258B2 (en) 2009-12-16 2014-07-08 Baxter International Inc. Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
JP6289096B2 (ja) 2010-06-01 2018-03-07 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血組成物を作製するためのプロセス
BR112012030455B1 (pt) 2010-06-01 2021-08-17 Baxter Healthcare S.A. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, e, kit para administrar uma composição hemostática
MX345479B (es) 2010-06-01 2017-02-01 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
US9381269B2 (en) 2011-04-13 2016-07-05 Avent, Inc. Biosorbable wound treatment device, process for making, and method of using the same
KR102135484B1 (ko) 2011-10-11 2020-07-20 백스터 인터내셔널 인코포레이티드 지혈 조성물
WO2013053759A2 (en) 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
SA112330957B1 (ar) 2011-10-27 2015-08-09 باكستر انترناشونال انك. تركيبات لإيقاف النزف
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
CA2874290C (en) 2012-06-12 2020-02-25 Ferrosan Medical Devices A/S Dry haemostatic composition
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
EP3316930B1 (en) 2015-07-03 2019-07-31 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
JP6523510B1 (ja) 2018-03-30 2019-06-05 Ｊｘ金属株式会社 スパッタリングターゲット
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2626257A (en) * 1952-05-21 1953-01-20 Johnson & Johnson Medical dusting powder
NL126243C (sv) * 1959-06-12
SE372421B (sv) * 1968-04-01 1974-12-23 Minnesota Mining & Mfg
JPS5439444B2 (sv) * 1971-08-21 1979-11-28

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Also Published As

Publication number Publication date
SE7407462L (sv) 1975-12-08
JPS517115A (sv) 1976-01-21
FR2273555B1 (sv) 1978-10-06
GB1518121A (en) 1978-07-19
DE2524279C2 (sv) 1990-07-12
CA1037950A (en) 1978-09-05
FR2273555A1 (fr) 1976-01-02
NL7506757A (nl) 1975-12-09
AU8164775A (en) 1976-12-02
DE2524279A1 (de) 1975-12-18
US4124705A (en) 1978-11-07
JPS6125689B2 (sv) 1986-06-17

Similar Documents

Publication Publication Date Title
SE420565B (sv) Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
SE7512996L (sv) Pediatrisk respirator
IL46919A0 (en) 16-oxygenated prostanoic acid derivatives and their preparation
BR7506325A (pt) Cateter medicinal de succao aperfeicoado
DK127575A (da) Filterenhed for blod
SE409856B (sv) Cyklopropankarboxylsyraestrar med insekticid och akaricid verkan
IL52283A0 (en) Blood oxygenator
SE440595B (sv) Forfaraande for framstellning av mjuka dinatriumkromoglykatpelletkulor for inhalering
SE393138B (sv) Forfarande for blekning av cellulosa med en syre innehallande gas i nervaro av natriumbikarbonat
GB1445964A (en) Diagnostic agent for the detection of glucose in urine
SE423315B (sv) Andningskateter
SE383046B (sv) Anordning for indikering av ett foremals legesforendringar
SE401182B (sv) Furanhydroxamsyraderivat med fungicid verkan
ZA75179B (en) New arylpiperazine derivatives of adenine and the preparation thereof
SE431204B (sv) Forfarande for framstellning av n?722-naftalensulfonyl-l-argininestrar och -amider eller farmaceutiskt accepterbara syraadditionssalter derav
FR2277577A1 (fr) Derives de l'acide prostanoique et medicaments qui en renferment
IT1036193B (it) Respiratore pediatrico
SE423236B (sv) Forfarande for framstellning av natriumsalter av amoxicillin
SE413280B (sv) Saett vid tillverkning av ett aetbart korvskinn av kollagen
FR2295042A1 (fr) Agents ignifugeants phosphores utilisables dans la preparation de polyurethannes
SE433217B (sv) Forfarande for framstellning av 6 aminopenicillansyra eller 7 aminocefalosporansyraderivat
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
SE7509897L (sv) Basiskt substituerade 3-sulfamoylbensoesyraderivat och forfarande for deras framstellning
IT962116B (it) Derivati dell acido 2 cloroetan fosfonico
IT1031883B (it) Preparazione di polioli

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7407462-6

Effective date: 19940710

Format of ref document f/p: F